Drugs / Hexbio
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05667038 | Mar 2022 → Aug 2023 | obesity disorder | King Saud University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hexbio | “Drug being used is Hexbio sachet containing 3g / 90 billion CFU.” NCT05667038 ↗ |
| Route | Oral | “The drug is consumed orally, two sachets per day” NCT05667038 ↗ |